Organogenesis Holdings ORGO
NASDAQ ORGO
$1.37 -0.02 (-1.44%)
As of: Sep 30, 2026 · 3:26 PM EDT

Organogenesis Holdings (ORGO) EBITDA Margin (2018 - 2026)

Updated

Organogenesis Holdings (ORGO) reported EBITDA Margin of -107.17% for Q2 2026, down 99.25 percentage points from -7.92% a year earlier but up 51.34 percentage points from the prior quarter.

Analysis

Organogenesis Holdings (ORGO) EBITDA Margin (2018 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Organogenesis Holdings' EBITDA Margin came in at -2.66%, down 1.46 percentage points year-over-year; for FY2025, it was 11.22%, up 7.95 percentage points from FY2024.

  • EBITDA Margin has a five-year change of +0.91 percentage points (FY2020 to FY2025).
  • By year, EBITDA Margin came in at 3.27% in FY2024 (-3.17 pp), 6.44% in FY2023 (-0.89 pp), 7.33% in FY2022 (-10.42 pp) and 17.75% in FY2021 (+7.44 pp).
  • Five-year quarterly EBITDA Margin spans a low of -158.51% in Q1 2026 and a high of 30.21% in Q4 2025.
  • Year over year, EBITDA Margin gained in three of the last eight quarters, with an average year-over-year change of -28.13 percentage points.
  • The high point for year-over-year EBITDA Margin in five years was Q4 2025 (a gain of 18.63 percentage points); the low point was Q1 2026 (a drop of 132.60 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -158.51% (Q1 2026), 30.21% (Q4 2025) and 16.97% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn 24.20%
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn 21.86%
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn 28.51%
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn 41.08%
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn 25.55%
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn 29.67%
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn 28.17%
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn 31.93%
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn 24.62%
10 Organogenesis Holdings 177.57 Mn -117.33 Mn 20.08 Mn -107.17%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -107.17%
Mar 31, 2026 -158.51%
Dec 31, 2025 30.21%
Sep 30, 2025 16.97%
Jun 30, 2025 -7.92%
Mar 31, 2025 -25.91%
Dec 31, 2024 11.58%
Sep 30, 2024 9.24%
Jun 30, 2024 -7.44%
Mar 31, 2024 0.11%
Dec 31, 2023 2.95%
Sep 30, 2023 10.89%
Jun 30, 2023 11.25%
Mar 31, 2023 -0.07%
Dec 31, 2022 9.91%
Sep 30, 2022 3.81%
Jun 30, 2022 12.10%
Mar 31, 2022 2.51%
Dec 31, 2021 17.79%
Sep 30, 2021 17.09%
API Access

Organogenesis Holdings EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ORGO&period=max&api_key=YOUR_API_KEY